Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 649

1.

Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.

Looijenga LH.

J Pathol. 2009 Jun;218(2):146-62. doi: 10.1002/path.2522. Review.

PMID:
19253916
2.

Stem cell factor as a novel diagnostic marker for early malignant germ cells.

Stoop H, Honecker F, van de Geijn GJ, Gillis AJ, Cools MC, de Boer M, Bokemeyer C, Wolffenbuttel KP, Drop SL, de Krijger RR, Dennis N, Summersgill B, McIntyre A, Shipley J, Oosterhuis JW, Looijenga LH.

J Pathol. 2008 Sep;216(1):43-54. doi: 10.1002/path.2378.

PMID:
18566970
3.

Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.

Looijenga LH, Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW.

Ann N Y Acad Sci. 2007 Dec;1120:187-214. Epub 2007 Oct 2. Review.

PMID:
17911410
4.

Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.

Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, Bokemeyer C, Li Y, Lau YF, Oosterhuis JW, Looijenga LH.

Hum Pathol. 2005 May;36(5):512-21.

PMID:
15948118
5.

Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.

Gillis AJ, Stoop H, Biermann K, van Gurp RJ, Swartzman E, Cribbes S, Ferlinz A, Shannon M, Oosterhuis JW, Looijenga LH.

Int J Androl. 2011 Aug;34(4 Pt 2):e160-74. doi: 10.1111/j.1365-2605.2011.01148.x. Epub 2011 Jun 2.

PMID:
21631526
7.

FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).

Hersmus R, Kalfa N, de Leeuw B, Stoop H, Oosterhuis JW, de Krijger R, Wolffenbuttel KP, Drop SL, Veitia RA, Fellous M, Jaubert F, Looijenga LH.

J Pathol. 2008 May;215(1):31-8. doi: 10.1002/path.2335.

PMID:
18348162
8.

Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.

Gopalan A, Dhall D, Olgac S, Fine SW, Korkola JE, Houldsworth J, Chaganti RS, Bosl GJ, Reuter VE, Tickoo SK.

Mod Pathol. 2009 Aug;22(8):1066-74. doi: 10.1038/modpathol.2009.66. Epub 2009 Apr 24.

9.

OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.

Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, Looijenga LH.

J Pathol. 2007 Jan;211(1):1-9. Review.

PMID:
17117392
10.

Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.

Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW.

Int J Androl. 2011 Aug;34(4 Pt 2):e234-51. doi: 10.1111/j.1365-2605.2011.01157.x. Epub 2011 May 12. Review.

PMID:
21564133
11.

The emerging phenotype of the testicular carcinoma in situ germ cell.

Rajpert-De Meyts E, Bartkova J, Samson M, Hoei-Hansen CE, Frydelund-Larsen L, Bartek J, Skakkebaek NE.

APMIS. 2003 Jan;111(1):267-78; discussion 278-9. Review.

PMID:
12752272
12.

Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men.

Hoei-Hansen CE.

Cancer Treat Rev. 2008 Jun;34(4):348-67. doi: 10.1016/j.ctrv.2007.12.007. Epub 2008 Mar 4. Review.

PMID:
18289797
13.

Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma.

Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J.

Int J Androl. 1987 Feb;10(1):19-28.

PMID:
3034791
14.

New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).

Hersmus R, de Leeuw BH, Wolffenbuttel KP, Drop SL, Oosterhuis JW, Cools M, Looijenga LH.

Mol Cell Endocrinol. 2008 Sep 10;291(1-2):1-10. doi: 10.1016/j.mce.2008.02.028. Epub 2008 Mar 4. Review.

PMID:
18403106
15.

[Embryonal germ cells and germ cell tumors].

Biermann K, Heukamp LC, Nettersheim D, Steger K, Zhou H, Franke FE, Guetgemann I, Sonnack V, Brehm R, Berg J, Bastian PJ, Müller SC, Wang-Eckert L, Schorle H, Büttner R.

Verh Dtsch Ges Pathol. 2007;91:39-48. German.

PMID:
18314594
16.

Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.

de Jong J, Stoop H, Dohle GR, Bangma CH, Kliffen M, van Esser JW, van den Bent M, Kros JM, Oosterhuis JW, Looijenga LH.

J Pathol. 2005 Jun;206(2):242-9.

PMID:
15818593
17.

Differential expression of SOX2 and SOX17 in testicular germ cell tumors.

Nonaka D.

Am J Clin Pathol. 2009 May;131(5):731-6. doi: 10.1309/AJCP7MNCNBCRN8NO.

PMID:
19369635
18.

Clinical and biological significance of carcinoma in situ of the testis.

Jørgensen N, Müller J, Giwercman A, Skakkebaek NE.

Cancer Surv. 1990;9(2):287-302. Review.

PMID:
1964624
19.

Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours.

Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW.

Int J Androl. 1998 Oct;21(5):283-8.

PMID:
9805244
20.

Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.

Rajpert-De Meyts E.

Hum Reprod Update. 2006 May-Jun;12(3):303-23. Epub 2006 Mar 15. Review.

PMID:
16540528

Supplemental Content

Support Center